| dc.contributor.author | Swanson, K. A. | |
| dc.contributor.author | Thomas, S. J. | |
| dc.contributor.author | Moreira, E. D. | |
| dc.contributor.author | Kitchin, N. | |
| dc.contributor.author | Absalon, J. | |
| dc.contributor.author | Gurtman, A. | |
| dc.contributor.author | Lockhart, S. | |
| dc.contributor.author | Perez, J. L. | |
| dc.contributor.author | Marc, G. Perez | |
| dc.contributor.author | Polack, F. P. | |
| dc.contributor.author | Zerbini, C. | |
| dc.contributor.author | Bailey, R. | |
| dc.contributor.author | Xu, X. | |
| dc.contributor.author | Roychoudhury, S. | |
| dc.contributor.author | Koury, K. | |
| dc.contributor.author | Bouguermouh, S. | |
| dc.contributor.author | Kalina, W. | |
| dc.contributor.author | Cooper, D. | |
| dc.contributor.author | Frenck, R. W. | |
| dc.contributor.author | Hammitt, L. L. | |
| dc.contributor.author | Tureci, O. | |
| dc.contributor.author | Nell, H. | |
| dc.contributor.author | Schaefer, A. | |
| dc.contributor.author | Unal, S. | |
| dc.contributor.author | Yang, Q. | |
| dc.contributor.author | Liberator, P. | |
| dc.contributor.author | Tresnan, D. B. | |
| dc.contributor.author | Mather, S. | |
| dc.contributor.author | Dormitzer, P. R. | |
| dc.contributor.author | Sahin, U. | |
| dc.contributor.author | Gruber, W. C. | |
| dc.contributor.author | Jansen, K. U. | |
| dc.date.accessioned | 2022-02-18T09:46:10Z | |
| dc.date.available | 2022-02-18T09:46:10Z | |
| dc.date.issued | 2021 | |
| dc.identifier.citation | Thomas S. J. , Moreira E. D. , Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J. L. , Marc G. P. , Polack F. P. , Zerbini C., et al., "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months", NEW ENGLAND JOURNAL OF MEDICINE, cilt.385, sa.19, ss.1761-1773, 2021 | |
| dc.identifier.issn | 0028-4793 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_5cff493d-a59a-437d-adc5-802c7681b262 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/177942 | |
| dc.identifier.uri | https://doi.org/10.1056/nejmoa2110345 | |
| dc.description.abstract | BACKGROUND | |
| dc.language.iso | eng | |
| dc.subject | General Medicine | |
| dc.subject | Health Sciences | |
| dc.subject | General Health Professions | |
| dc.subject | TIP, GENEL & İÇECEK | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Temel Tıp Bilimleri | |
| dc.subject | Family Practice | |
| dc.subject | Fundamentals and Skills | |
| dc.subject | Pathophysiology | |
| dc.subject | Internal Medicine | |
| dc.subject | Assessment and Diagnosis | |
| dc.subject | Medicine (miscellaneous) | |
| dc.title | Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months | |
| dc.type | Makale | |
| dc.relation.journal | NEW ENGLAND JOURNAL OF MEDICINE | |
| dc.contributor.department | State University of New York (SUNY) System , , | |
| dc.identifier.volume | 385 | |
| dc.identifier.issue | 19 | |
| dc.identifier.startpage | 1761 | |
| dc.identifier.endpage | 1773 | |
| dc.contributor.firstauthorID | 3388390 | |
